nodes	percent_of_prediction	percent_of_DWPC	metapath
Baclofen—Ibuprofen—CXCL8—chronic obstructive pulmonary disease	0.00631	0.794	CrCbGaD
Baclofen—GABBR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00483	0.0697	CbGpPWpGaD
Baclofen—GABBR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00394	0.0568	CbGpPWpGaD
Baclofen—GABBR2—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00363	0.0524	CbGpPWpGaD
Baclofen—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA5—chronic obstructive pulmonary disease	0.00311	0.0449	CbGpPWpGaD
Baclofen—GABBR2—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00296	0.0427	CbGpPWpGaD
Baclofen—GABBR2—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00278	0.0401	CbGpPWpGaD
Baclofen—GABBR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—CHRNA3—chronic obstructive pulmonary disease	0.00254	0.0366	CbGpPWpGaD
Baclofen—GABBR2—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.00242	0.0349	CbGpPWpGaD
Baclofen—GABBR1—Transmission across Chemical Synapses—CHRNA5—chronic obstructive pulmonary disease	0.00234	0.0338	CbGpPWpGaD
Baclofen—GABBR2—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00227	0.0327	CbGpPWpGaD
Baclofen—GABBR1—Transmission across Chemical Synapses—CHRNA3—chronic obstructive pulmonary disease	0.00191	0.0275	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—CHRNA5—chronic obstructive pulmonary disease	0.00179	0.0259	CbGpPWpGaD
Baclofen—Ibuprofen—ALB—chronic obstructive pulmonary disease	0.00164	0.206	CrCbGaD
Baclofen—GABBR1—G alpha (i) signalling events—CXCR2—chronic obstructive pulmonary disease	0.00156	0.0225	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.00146	0.0211	CbGpPWpGaD
Baclofen—GABBR1—Neuronal System—CHRNA3—chronic obstructive pulmonary disease	0.00146	0.0211	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.0012	0.0173	CbGpPWpGaD
Baclofen—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00119	0.00129	CcSEcCtD
Baclofen—Palpitations—Salbutamol—chronic obstructive pulmonary disease	0.00118	0.00128	CcSEcCtD
Baclofen—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00118	0.00128	CcSEcCtD
Baclofen—Dry mouth—Formoterol—chronic obstructive pulmonary disease	0.00118	0.00128	CcSEcCtD
Baclofen—Dry mouth—Arformoterol—chronic obstructive pulmonary disease	0.00118	0.00128	CcSEcCtD
Baclofen—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00118	0.00127	CcSEcCtD
Baclofen—Loss of consciousness—Salbutamol—chronic obstructive pulmonary disease	0.00117	0.00127	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00117	0.00127	CcSEcCtD
Baclofen—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00117	0.00127	CcSEcCtD
Baclofen—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00115	0.00125	CcSEcCtD
Baclofen—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00115	0.00125	CcSEcCtD
Baclofen—Hypertension—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00125	CcSEcCtD
Baclofen—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00115	0.00124	CcSEcCtD
Baclofen—Infection—Formoterol—chronic obstructive pulmonary disease	0.00115	0.00124	CcSEcCtD
Baclofen—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00123	CcSEcCtD
Baclofen—Chest pain—Salbutamol—chronic obstructive pulmonary disease	0.00114	0.00123	CcSEcCtD
Baclofen—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00114	0.00123	CcSEcCtD
Baclofen—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00113	0.00123	CcSEcCtD
Baclofen—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00113	0.00123	CcSEcCtD
Baclofen—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00113	0.00123	CcSEcCtD
Baclofen—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00113	0.00123	CcSEcCtD
Baclofen—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00113	0.00123	CcSEcCtD
Baclofen—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.00113	0.00122	CcSEcCtD
Baclofen—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.00113	0.00122	CcSEcCtD
Baclofen—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00112	0.00122	CcSEcCtD
Baclofen—Infection—Montelukast—chronic obstructive pulmonary disease	0.00112	0.00122	CcSEcCtD
Baclofen—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.00112	0.00122	CcSEcCtD
Baclofen—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00112	0.00122	CcSEcCtD
Baclofen—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00112	0.00122	CcSEcCtD
Baclofen—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.00111	0.00121	CcSEcCtD
Baclofen—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00111	0.0012	CcSEcCtD
Baclofen—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.0011	0.0012	CcSEcCtD
Baclofen—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.0011	0.00119	CcSEcCtD
Baclofen—Euphoric mood—Prednisone—chronic obstructive pulmonary disease	0.00109	0.00119	CcSEcCtD
Baclofen—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00109	0.00118	CcSEcCtD
Baclofen—Infection—Salbutamol—chronic obstructive pulmonary disease	0.00108	0.00117	CcSEcCtD
Baclofen—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00108	0.00117	CcSEcCtD
Baclofen—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00108	0.00117	CcSEcCtD
Baclofen—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00107	0.00116	CcSEcCtD
Baclofen—Shock—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00116	CcSEcCtD
Baclofen—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.00107	0.00116	CcSEcCtD
Baclofen—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00107	0.00116	CcSEcCtD
Baclofen—Thrombophlebitis—Prednisone—chronic obstructive pulmonary disease	0.00107	0.00116	CcSEcCtD
Baclofen—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.00115	CcSEcCtD
Baclofen—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00106	0.00115	CcSEcCtD
Baclofen—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.00105	0.00114	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00114	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00114	CcSEcCtD
Baclofen—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00104	0.00113	CcSEcCtD
Baclofen—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00104	0.00113	CcSEcCtD
Baclofen—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00104	0.00113	CcSEcCtD
Baclofen—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00104	0.00112	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00103	0.00112	CcSEcCtD
Baclofen—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00103	0.00112	CcSEcCtD
Baclofen—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00103	0.00112	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.00103	0.0148	CbGpPWpGaD
Baclofen—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.00103	0.00111	CcSEcCtD
Baclofen—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.00103	0.00111	CcSEcCtD
Baclofen—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00102	0.00111	CcSEcCtD
Baclofen—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00102	0.0011	CcSEcCtD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00102	0.0147	CbGpPWpGaD
Baclofen—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.00102	0.0011	CcSEcCtD
Baclofen—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.00102	0.0011	CcSEcCtD
Baclofen—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00102	0.0011	CcSEcCtD
Baclofen—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00101	0.0011	CcSEcCtD
Baclofen—Injury—Prednisone—chronic obstructive pulmonary disease	0.00101	0.00109	CcSEcCtD
Baclofen—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.00101	0.00109	CcSEcCtD
Baclofen—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.001	0.00109	CcSEcCtD
Baclofen—Weight increased—Prednisolone—chronic obstructive pulmonary disease	0.001	0.00108	CcSEcCtD
Baclofen—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000997	0.00108	CcSEcCtD
Baclofen—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000997	0.00108	CcSEcCtD
Baclofen—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000995	0.00108	CcSEcCtD
Baclofen—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000995	0.00108	CcSEcCtD
Baclofen—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000995	0.00108	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000993	0.00108	CcSEcCtD
Baclofen—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000987	0.00107	CcSEcCtD
Baclofen—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000987	0.00107	CcSEcCtD
Baclofen—Pain—Formoterol—chronic obstructive pulmonary disease	0.000987	0.00107	CcSEcCtD
Baclofen—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000987	0.00107	CcSEcCtD
Baclofen—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000986	0.00107	CcSEcCtD
Baclofen—Amnesia—Prednisone—chronic obstructive pulmonary disease	0.000984	0.00107	CcSEcCtD
Baclofen—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000979	0.00106	CcSEcCtD
Baclofen—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000976	0.00106	CcSEcCtD
Baclofen—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000975	0.00106	CcSEcCtD
Baclofen—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000972	0.00105	CcSEcCtD
Baclofen—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.000969	0.00105	CcSEcCtD
Baclofen—Pain—Montelukast—chronic obstructive pulmonary disease	0.000967	0.00105	CcSEcCtD
Baclofen—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000964	0.00105	CcSEcCtD
Baclofen—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000959	0.00104	CcSEcCtD
Baclofen—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000956	0.00104	CcSEcCtD
Baclofen—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000955	0.00104	CcSEcCtD
Baclofen—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000951	0.00103	CcSEcCtD
Baclofen—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000951	0.00103	CcSEcCtD
Baclofen—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00095	0.00103	CcSEcCtD
Baclofen—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000947	0.00103	CcSEcCtD
Baclofen—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.000946	0.00103	CcSEcCtD
Baclofen—GABBR1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000944	0.0136	CbGpPWpGaD
Baclofen—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000944	0.00102	CcSEcCtD
Baclofen—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000944	0.00102	CcSEcCtD
Baclofen—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.000943	0.00102	CcSEcCtD
Baclofen—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000941	0.00102	CcSEcCtD
Baclofen—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00094	0.00102	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000933	0.0135	CbGpPWpGaD
Baclofen—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000932	0.00101	CcSEcCtD
Baclofen—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000932	0.00101	CcSEcCtD
Baclofen—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000925	0.001	CcSEcCtD
Baclofen—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.000924	0.001	CcSEcCtD
Baclofen—Gastrointestinal haemorrhage—Prednisone—chronic obstructive pulmonary disease	0.000924	0.001	CcSEcCtD
Baclofen—GABBR2—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000919	0.0133	CbGpPWpGaD
Baclofen—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000917	0.000994	CcSEcCtD
Baclofen—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000917	0.000994	CcSEcCtD
Baclofen—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000913	0.000989	CcSEcCtD
Baclofen—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000913	0.000989	CcSEcCtD
Baclofen—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000913	0.000989	CcSEcCtD
Baclofen—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000913	0.000989	CcSEcCtD
Baclofen—Affect lability—Prednisone—chronic obstructive pulmonary disease	0.00091	0.000986	CcSEcCtD
Baclofen—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000909	0.000986	CcSEcCtD
Baclofen—SLC22A8—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000907	0.0131	CbGpPWpGaD
Baclofen—Psychotic disorder—Prednisone—chronic obstructive pulmonary disease	0.000903	0.000978	CcSEcCtD
Baclofen—Rash—Tiotropium—chronic obstructive pulmonary disease	0.000902	0.000977	CcSEcCtD
Baclofen—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.000901	0.000976	CcSEcCtD
Baclofen—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.000901	0.000976	CcSEcCtD
Baclofen—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000898	0.000973	CcSEcCtD
Baclofen—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000898	0.000973	CcSEcCtD
Baclofen—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000896	0.000971	CcSEcCtD
Baclofen—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000896	0.000971	CcSEcCtD
Baclofen—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000894	0.000969	CcSEcCtD
Baclofen—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000894	0.000969	CcSEcCtD
Baclofen—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000892	0.000967	CcSEcCtD
Baclofen—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000891	0.000966	CcSEcCtD
Baclofen—Mood swings—Prednisone—chronic obstructive pulmonary disease	0.000876	0.000949	CcSEcCtD
Baclofen—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000866	0.000938	CcSEcCtD
Baclofen—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000862	0.000934	CcSEcCtD
Baclofen—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000862	0.000934	CcSEcCtD
Baclofen—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.00085	0.000921	CcSEcCtD
Baclofen—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000848	0.000919	CcSEcCtD
Baclofen—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000828	0.000898	CcSEcCtD
Baclofen—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000828	0.000898	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000828	0.0119	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000821	0.0118	CbGpPWpGaD
Baclofen—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000817	0.000885	CcSEcCtD
Baclofen—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000817	0.000885	CcSEcCtD
Baclofen—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000815	0.000883	CcSEcCtD
Baclofen—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.000811	0.000879	CcSEcCtD
Baclofen—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.0008	0.000867	CcSEcCtD
Baclofen—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00079	0.000856	CcSEcCtD
Baclofen—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00079	0.000856	CcSEcCtD
Baclofen—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000786	0.000852	CcSEcCtD
Baclofen—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000782	0.000848	CcSEcCtD
Baclofen—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000778	0.000843	CcSEcCtD
Baclofen—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000774	0.000838	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000773	0.0112	CbGpPWpGaD
Baclofen—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000771	0.000836	CcSEcCtD
Baclofen—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000763	0.000827	CcSEcCtD
Baclofen—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000763	0.000827	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000752	0.0108	CbGpPWpGaD
Baclofen—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000748	0.00081	CcSEcCtD
Baclofen—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000746	0.000808	CcSEcCtD
Baclofen—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000736	0.000797	CcSEcCtD
Baclofen—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000734	0.000795	CcSEcCtD
Baclofen—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000734	0.000795	CcSEcCtD
Baclofen—GABBR2—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000733	0.0106	CbGpPWpGaD
Baclofen—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000728	0.000789	CcSEcCtD
Baclofen—Rash—Formoterol—chronic obstructive pulmonary disease	0.000728	0.000789	CcSEcCtD
Baclofen—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000727	0.000788	CcSEcCtD
Baclofen—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000727	0.000788	CcSEcCtD
Baclofen—Weight increased—Prednisone—chronic obstructive pulmonary disease	0.000727	0.000788	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000727	0.0105	CbGpPWpGaD
Baclofen—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000723	0.000784	CcSEcCtD
Baclofen—Headache—Formoterol—chronic obstructive pulmonary disease	0.000723	0.000784	CcSEcCtD
Baclofen—Weight decreased—Prednisone—chronic obstructive pulmonary disease	0.000723	0.000783	CcSEcCtD
Baclofen—Vision blurred—Prednisolone—chronic obstructive pulmonary disease	0.000722	0.000782	CcSEcCtD
Baclofen—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000721	0.000781	CcSEcCtD
Baclofen—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.000721	0.000781	CcSEcCtD
Baclofen—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000719	0.000779	CcSEcCtD
Baclofen—GABBR2—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000718	0.0104	CbGpPWpGaD
Baclofen—Rash—Montelukast—chronic obstructive pulmonary disease	0.000713	0.000773	CcSEcCtD
Baclofen—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000712	0.000772	CcSEcCtD
Baclofen—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000711	0.00077	CcSEcCtD
Baclofen—Depression—Prednisone—chronic obstructive pulmonary disease	0.00071	0.00077	CcSEcCtD
Baclofen—Headache—Montelukast—chronic obstructive pulmonary disease	0.000708	0.000768	CcSEcCtD
Baclofen—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000693	0.000751	CcSEcCtD
Baclofen—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000691	0.000749	CcSEcCtD
Baclofen—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000688	0.000746	CcSEcCtD
Baclofen—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000687	0.000745	CcSEcCtD
Baclofen—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000687	0.000744	CcSEcCtD
Baclofen—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000687	0.000744	CcSEcCtD
Baclofen—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000686	0.000743	CcSEcCtD
Baclofen—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000686	0.000743	CcSEcCtD
Baclofen—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000683	0.00074	CcSEcCtD
Baclofen—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000673	0.00073	CcSEcCtD
Baclofen—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000672	0.000728	CcSEcCtD
Baclofen—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000664	0.000719	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000662	0.00954	CbGpPWpGaD
Baclofen—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000661	0.000717	CcSEcCtD
Baclofen—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000651	0.000705	CcSEcCtD
Baclofen—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000647	0.000702	CcSEcCtD
Baclofen—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000644	0.000698	CcSEcCtD
Baclofen—Hallucination—Prednisone—chronic obstructive pulmonary disease	0.000636	0.00069	CcSEcCtD
Baclofen—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000628	0.000681	CcSEcCtD
Baclofen—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000625	0.000678	CcSEcCtD
Baclofen—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000615	0.000667	CcSEcCtD
Baclofen—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.00061	0.000661	CcSEcCtD
Baclofen—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000604	0.000655	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000601	0.00867	CbGpPWpGaD
Baclofen—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000598	0.000648	CcSEcCtD
Baclofen—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000593	0.000643	CcSEcCtD
Baclofen—GABBR1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000592	0.00854	CbGpPWpGaD
Baclofen—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.00058	0.000629	CcSEcCtD
Baclofen—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000571	0.000619	CcSEcCtD
Baclofen—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000565	0.000613	CcSEcCtD
Baclofen—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000565	0.000612	CcSEcCtD
Baclofen—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000561	0.000608	CcSEcCtD
Baclofen—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.00056	0.000607	CcSEcCtD
Baclofen—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000557	0.000603	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000551	0.00795	CbGpPWpGaD
Baclofen—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000535	0.000579	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000533	0.00769	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000529	0.00763	CbGpPWpGaD
Baclofen—Vision blurred—Prednisone—chronic obstructive pulmonary disease	0.000525	0.000569	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000519	0.00749	CbGpPWpGaD
Baclofen—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000516	0.00056	CcSEcCtD
Baclofen—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000515	0.000558	CcSEcCtD
Baclofen—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000514	0.000558	CcSEcCtD
Baclofen—Agitation—Prednisone—chronic obstructive pulmonary disease	0.000512	0.000554	CcSEcCtD
Baclofen—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000502	0.000544	CcSEcCtD
Baclofen—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.0005	0.000542	CcSEcCtD
Baclofen—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000499	0.000541	CcSEcCtD
Baclofen—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000497	0.000538	CcSEcCtD
Baclofen—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000489	0.00053	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000484	0.00699	CbGpPWpGaD
Baclofen—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000482	0.000523	CcSEcCtD
Baclofen—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000481	0.000521	CcSEcCtD
Baclofen—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000474	0.000514	CcSEcCtD
Baclofen—GABBR1—G alpha (i) signalling events—CXCL8—chronic obstructive pulmonary disease	0.000472	0.00681	CbGpPWpGaD
Baclofen—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.000472	0.000512	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000472	0.0068	CbGpPWpGaD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000471	0.00051	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.000468	0.00676	CbGpPWpGaD
Baclofen—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000468	0.000507	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000464	0.00669	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000463	0.00668	CbGpPWpGaD
Baclofen—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000454	0.000492	CcSEcCtD
Baclofen—Infection—Prednisone—chronic obstructive pulmonary disease	0.000451	0.000489	CcSEcCtD
Baclofen—Shock—Prednisone—chronic obstructive pulmonary disease	0.000447	0.000484	CcSEcCtD
Baclofen—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000446	0.000483	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000444	0.0064	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000444	0.0064	CbGpPWpGaD
Baclofen—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000443	0.000481	CcSEcCtD
Baclofen—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000441	0.000478	CcSEcCtD
Baclofen—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000439	0.000476	CcSEcCtD
Baclofen—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000433	0.000469	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000421	0.00608	CbGpPWpGaD
Baclofen—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000414	0.000449	CcSEcCtD
Baclofen—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000413	0.000448	CcSEcCtD
Baclofen—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000411	0.000445	CcSEcCtD
Baclofen—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000408	0.000442	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000406	0.00586	CbGpPWpGaD
Baclofen—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.0004	0.000433	CcSEcCtD
Baclofen—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000395	0.000428	CcSEcCtD
Baclofen—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000394	0.000427	CcSEcCtD
Baclofen—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000394	0.000427	CcSEcCtD
Baclofen—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000392	0.000424	CcSEcCtD
Baclofen—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000392	0.000424	CcSEcCtD
Baclofen—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000388	0.000421	CcSEcCtD
Baclofen—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000374	0.000406	CcSEcCtD
Baclofen—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000371	0.000403	CcSEcCtD
Baclofen—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000371	0.000402	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000369	0.00532	CbGpPWpGaD
Baclofen—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000361	0.000391	CcSEcCtD
Baclofen—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000359	0.000389	CcSEcCtD
Baclofen—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000359	0.000389	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000355	0.00512	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000335	0.00483	CbGpPWpGaD
Baclofen—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000326	0.000353	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000325	0.00468	CbGpPWpGaD
Baclofen—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000321	0.000348	CcSEcCtD
Baclofen—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000311	0.000337	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000304	0.00438	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000302	0.00435	CbGpPWpGaD
Baclofen—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.0003	0.000326	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000299	0.00431	CbGpPWpGaD
Baclofen—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000289	0.000313	CcSEcCtD
Baclofen—Rash—Prednisone—chronic obstructive pulmonary disease	0.000286	0.00031	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.000286	0.00413	CbGpPWpGaD
Baclofen—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000286	0.00031	CcSEcCtD
Baclofen—GABBR1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.000286	0.00412	CbGpPWpGaD
Baclofen—Headache—Prednisone—chronic obstructive pulmonary disease	0.000285	0.000308	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.000279	0.00402	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000272	0.00392	CbGpPWpGaD
Baclofen—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00027	0.000292	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000262	0.00377	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000251	0.00362	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.000249	0.00359	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	0.000238	0.00343	CbGpPWpGaD
Baclofen—SLC22A8—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000236	0.0034	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000228	0.00328	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000226	0.00326	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.000218	0.00314	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	0.000209	0.00302	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.000202	0.00292	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.0002	0.00288	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—KL—chronic obstructive pulmonary disease	0.000195	0.00281	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	0.00018	0.00259	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.000166	0.0024	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	0.000162	0.00233	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	0.00016	0.00231	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000159	0.00229	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	0.000152	0.00219	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	0.000147	0.00212	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	0.000146	0.0021	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	0.00014	0.00202	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	0.000135	0.00194	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	0.00013	0.00188	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	0.000128	0.00185	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	0.000122	0.00176	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	0.00012	0.00173	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	0.000109	0.00158	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	0.000107	0.00155	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	0.000102	0.00148	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	0.0001	0.00145	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	9.83e-05	0.00142	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	9.77e-05	0.00141	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	8.67e-05	0.00125	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—TP53—chronic obstructive pulmonary disease	8.26e-05	0.00119	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	8.24e-05	0.00119	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	7.84e-05	0.00113	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IL6—chronic obstructive pulmonary disease	7.56e-05	0.00109	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	7.04e-05	0.00102	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	6.46e-05	0.000932	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	6.34e-05	0.000914	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	5.32e-05	0.000767	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	4.87e-05	0.000702	CbGpPWpGaD
